Table 1 Demographic and clinical characteristics
Characteristics | Overall | Benign Thy3 | Malignant Thy3 | P - value† | Odds ratio (95% confidence interval) |
|---|---|---|---|---|---|
Number of patients | 99 (100) | 81 (81.81) | 18 (18.18) | ||
Sex | |||||
female | 79 (79.79) | 64 (81.01) | 15 (18.99) | 0.68 | 1.33 (0.34, 5.12) |
male | 20 (20.21) | 17 (85) | 3 (15) | Ref | |
Age (years) | |||||
< 55 | 64 (64.64) | 52 (81.25) | 12 (18.75) | 0.84 | 1.12 (0.38, 3.29) |
≥ 55 | 35 (35.35) | 29 (82.85) | 6 (17.14) | Ref | |
Age (years) | Mean: 49.3 | Mean: 49.5 | Mean: 48.4 | 0.75¶ | 1.01 (0.97, 1.05) |
SD: 13.2 | SD: 13.1 | SD: 13.7 | |||
BMI (kg/m2) | |||||
≤ 30 | 78 (78.78) | 64 (82.05) | 14 (17.95) | 0.91 | Ref |
> 30 | 21 (21.21) | 17 (80.95) | 4 (19.04) | 1.08 (0.31, 3.69) | |
BMI (kg/m2) | Median: 25.6 | Median: 25.2 | Median: 26.45 | 0.76¶ | 0.99 (0.89, 1.08) |
IQR: 6.3 | IQR: 6.8 | IQR: 6.3 | |||
Hashimoto’s /Graves’ | |||||
Yes | 31 (31.31) | 25 (80.6) | 6 (19.4) | 0.84 | 1.12 (0.38, 3.32) |
No | 68 (68.68) | 56 (82.4) | 12 (17.6) | Ref | |